[124]
Qian HS, Guo HC, Ho PCL, Mahendran R, Zhang Y. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. small 2009; 5(20): 2285-90.
[131]
Liu HM, Wu SH, Lu CW, et al. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. small 2008; 4(5): 619-26.
[152]
Singh H, Sreedharan S, Oyarzabal E, et al. Mitochondriotropic Lanthanide Nanorods: Implications for Multimodal Imaging. Chem Comm 2020.
[159]
Popp MK, Oubou I, Shepherd C, Nager Z, Anderson C, Pagliaro L. Photothermal therapy using gold nanorods and near-infrared light in a murine melanoma model increases survival and decreases tumor volume. J Nanomater 2014 2014.
[181]
Kharlamov AN, Feinstein JA, Cramer JA, Boothroyd JA, Shishkina EV, Shur V. Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM- FIM trial. Future Cardiol 2017; 13(4): 345-63.
[182]
Singh P, Pandit S, Mokkapati VR, Garg A, Ravikumar V, Mijakovic I. Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci 2018; 19(7): 1979.
[183]
Bayda S, Hadla M, Palazzolo S, et al. Inorganic nanoparticles for cancer therapy: a transition from lab to clinic. Curr Med Chem 2018; 25(34): 4269-303.
[184]
Guryev EL, Shilyagina NY, Kostyuk AB, Sencha LM, Balalaeva IV, Vodeneev VA, et al. Preclinical study of biofunctional polymer-coated upconversion nanoparticles. Toxicol. SciToxicological Sciences 2019; 170(1): 123-32.
[185]
Lv R, Li G, Lu S, Wang T. Synthesis of multi-functional carbon quantum dots for targeted antitumor therapy. J. Fluoresc 2021; 31: pp. (2)339-48.
[186]
Adrita SH, Tasnim KN, Ryu JH, Sharker SM. Nanotheranostic carbon dots as an emerging platform for cancer therapy. J Nanotheranostics 2020; 1(1): 59-78.
[187]
Jia Q, Zhao Z, Liang K, et al. Recent advances and prospects of carbon dots in cancer nanotheranostics. Mater Chem Front 2020; 4(2): 449-71.
[188]
Del Rosal B, Jaque D. Upconversion nanoparticles for in vivo applications: limitations and future perspectives. Methods Appl. Fluoresc. Methods Appl Fluoresc 2019; 7(2)022001
[189]
Oliveira H, Bednarkiewicz A, Falk A, Fröhlich E, Lisjak D, Prina-Mello A, et al. Critical considerations on the clinical translation of upconversion nanoparticles (UCNPs): recommendations from the European upconversion network (COST Action CM1403). Adv Healthc Mater 2019; 8(1)1801233
[190]
Jia Q, Zhao Z, Liang K, et al. Recent advances and prospects of carbon dots in cancer nanotheranostics. Mater Chem Front 2020; 4(2): 449-71.